 Luis Cava
Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgical Procedures | 2 | 2024 | 168 | 0.340 |
Why?
| | Stroke | 6 | 2019 | 1111 | 0.310 |
Why?
| | Brain Ischemia | 4 | 2014 | 308 | 0.250 |
Why?
| | Midazolam | 1 | 2024 | 49 | 0.230 |
Why?
| | Hypnotics and Sedatives | 1 | 2024 | 158 | 0.210 |
Why?
| | Thrombolytic Therapy | 3 | 2014 | 137 | 0.200 |
Why?
| | Reperfusion | 2 | 2011 | 37 | 0.180 |
Why?
| | Spinal Cord Vascular Diseases | 1 | 2018 | 4 | 0.160 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2018 | 16 | 0.160 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 36 | 0.150 |
Why?
| | Baroreflex | 1 | 2019 | 61 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2018 | 62 | 0.150 |
Why?
| | Antibodies, Bacterial | 1 | 2018 | 137 | 0.140 |
Why?
| | Piracetam | 1 | 2017 | 15 | 0.140 |
Why?
| | Immunity, Humoral | 1 | 2018 | 117 | 0.140 |
Why?
| | Hemofiltration | 1 | 2017 | 31 | 0.140 |
Why?
| | Pneumococcal Vaccines | 1 | 2018 | 140 | 0.140 |
Why?
| | Intracranial Hemorrhages | 1 | 2017 | 77 | 0.130 |
Why?
| | Cerebellar Diseases | 1 | 2016 | 23 | 0.130 |
Why?
| | Aneurysm, Ruptured | 1 | 2016 | 35 | 0.130 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2016 | 52 | 0.130 |
Why?
| | Intracranial Aneurysm | 1 | 2016 | 95 | 0.120 |
Why?
| | Anticonvulsants | 1 | 2017 | 199 | 0.120 |
Why?
| | Angiography, Digital Subtraction | 2 | 2011 | 45 | 0.120 |
Why?
| | Cerebral Angiography | 2 | 2011 | 111 | 0.120 |
Why?
| | Ultrasonography, Doppler, Transcranial | 2 | 2011 | 40 | 0.120 |
Why?
| | Vancomycin | 1 | 2015 | 79 | 0.110 |
Why?
| | Embolization, Therapeutic | 1 | 2016 | 209 | 0.110 |
Why?
| | Burns | 1 | 2018 | 286 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2018 | 834 | 0.110 |
Why?
| | Intracranial Thrombosis | 1 | 2013 | 17 | 0.110 |
Why?
| | Ultrasonic Therapy | 1 | 2013 | 12 | 0.110 |
Why?
| | Heart-Assist Devices | 1 | 2019 | 529 | 0.100 |
Why?
| | Endovascular Procedures | 1 | 2016 | 304 | 0.100 |
Why?
| | Intracranial Arteriosclerosis | 1 | 2011 | 8 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1743 | 0.090 |
Why?
| | Cerebrovascular Circulation | 2 | 2011 | 223 | 0.090 |
Why?
| | Aged | 11 | 2024 | 22035 | 0.090 |
Why?
| | Positive-Pressure Respiration | 1 | 2011 | 75 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2014 | 387 | 0.090 |
Why?
| | Hypertension | 1 | 2019 | 1236 | 0.080 |
Why?
| | Brain | 2 | 2018 | 2592 | 0.080 |
Why?
| | Middle Aged | 11 | 2024 | 30977 | 0.080 |
Why?
| | Nervous System Diseases | 1 | 2011 | 260 | 0.080 |
Why?
| | Regional Blood Flow | 1 | 2010 | 462 | 0.070 |
Why?
| | Critical Illness | 2 | 2024 | 753 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2142 | 0.060 |
Why?
| | Intensive Care Units | 2 | 2024 | 730 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1701 | 0.060 |
Why?
| | Adult | 8 | 2024 | 35361 | 0.050 |
Why?
| | Prospective Studies | 3 | 2024 | 7060 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2024 | 484 | 0.050 |
Why?
| | Male | 10 | 2024 | 63146 | 0.050 |
Why?
| | Tandem Mass Spectrometry | 1 | 2024 | 441 | 0.050 |
Why?
| | Female | 10 | 2024 | 68162 | 0.050 |
Why?
| | Humans | 13 | 2024 | 128896 | 0.040 |
Why?
| | Acute Disease | 2 | 2014 | 978 | 0.040 |
Why?
| | Embolectomy | 1 | 2014 | 14 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 395 | 0.030 |
Why?
| | Seizures | 1 | 2017 | 395 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1213 | 0.030 |
Why?
| | Mechanical Thrombolysis | 1 | 2013 | 5 | 0.030 |
Why?
| | Equipment Safety | 1 | 2013 | 40 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 2 | 2014 | 2530 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2014 | 225 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 729 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2634 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2013 | 128 | 0.020 |
Why?
| | Facial Paralysis | 1 | 2011 | 20 | 0.020 |
Why?
| | Basilar Artery | 1 | 2011 | 7 | 0.020 |
Why?
| | Aphasia | 1 | 2011 | 20 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 264 | 0.020 |
Why?
| | Perfusion Imaging | 1 | 2011 | 57 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 366 | 0.020 |
Why?
| | Middle Cerebral Artery | 1 | 2011 | 45 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 7050 | 0.020 |
Why?
| | Hypercapnia | 1 | 2011 | 56 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 230 | 0.020 |
Why?
| | Critical Care | 1 | 2015 | 547 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2011 | 232 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2010 | 413 | 0.020 |
Why?
| | Brain Mapping | 1 | 2011 | 562 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2015 | 786 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2015 | 14546 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1840 | 0.020 |
Why?
| | Young Adult | 2 | 2015 | 12286 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1967 | 0.020 |
Why?
| | Hemodynamics | 1 | 2010 | 1095 | 0.010 |
Why?
| | Blood Glucose | 1 | 2014 | 2086 | 0.010 |
Why?
| | Adolescent | 2 | 2015 | 20197 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 3787 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3348 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 9792 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6568 | 0.010 |
Why?
| | Animals | 1 | 2019 | 34628 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 10239 | 0.010 |
Why?
| | Child | 1 | 2010 | 20824 | 0.010 |
Why?
|
|
Cava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|